| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Dilaudid (hydromorphone HCl, USP) Liquid & Tablets, 1 mg/mL & 8 mg respectively, Abbott NDA 19-891/S-002 & 19-892/S-002 Hydromorphone Hydrochloride Injection, Faulding Pharmaceutical ANDA 76-444 4/25/03 Hydromorphone Hydrochloride Solution, 5 mg/5 mL, Roxane ANDA 74-653 7/29/98 8/5/98 Hydromorphone Hydrochloride Tablets USP, 8 mg, Roxane ANDA 74-597 HYDROMORPHONE HYDROCHLORIDE Injection 10MG/ML DILAUDID-HP ABBOTT 074598 HYDROMORPHONE HYDROCHLORIDE Injection 10MG/ML HYDROMORPHONE HCL ABBOTT 019034 HYDROMORPHONE HYDROCHLORIDE Injection 250MG/VIAL DILAUDID-HP ABBOTT 076444 HYDROMORPHONE HYDROCHLORIDE Injection 10MG/ML HYDROMORPHONE HCL FAULDING 074317 HYDROMORPHONE HYDROCHLORIDE Injection 10MG/ML HYDROMORPHONE HCL STERIS 019891 HYDROMORPHONE HYDROCHLORIDE Solution; 5MG/5ML DILAUDID ABBOTT 074653 HYDROMORPHONE HYDROCHLORIDE Solution; 5MG/5ML HYDROMORPHONE HCL ROXANE 019892 HYDROMORPHONE HYDROCHLORIDE Tablet; 8MG DILAUDID ABBOTT 074597 HYDROMORPHONE HYDROCHLORIDE Tablet; 8MG HYDROMORPHONE HCL ROXANE |
© 2007 Betterchem Corp.
|